Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$20.65

-2.05 (-9.03%)

14:56
06/12/17
06/12
14:56
06/12/17
14:56

Coherus price target lowered to $33 after complete response letter at Citi

Citi analyst Mohit Bansal, in an intraday follow up note on Coherus Biosciences, lowered his price target on the stock to $33 from $38, stating that the CRL for its Neulasta biosimilar creates uncertainty and delays the product's potential launch by about one year. The analyst, who noted that a positive Supreme Court decision today eliminates a 180 day notice after approval and could expedite launch for the drug by six months, keeps a Buy rating on Coherus shares.

  • 12

    Jun

CHRS Coherus Biosciences
$20.65

-2.05 (-9.03%)

06/12/17
FBCO
06/12/17
NO CHANGE
Target $38
FBCO
Outperform
Credit Suisse 'cautiously optimistic' on timelines laid out by Coherus
Credit Suisse analyst Alethia Young reiterates her previous belief that shares of Coherus Biosciences could trade to $12-$15 based on a complete response letter scenario. The CRL news today is not worst case, however, as there were not major issues like running wrong clinical studies, manufacturing and fill-finish, Young tells investors in a research note. The analyst believes approval of CHS-1701 remains the catalyst for Coherus. This means the key catalyst is likely shifted until mid or second half of 2018. Young writes. The analyst is "cautiously optimistic" on the timelines laid out by management and keeps an Outperform rating on the shares. The stock in morning trading is down 27% to $15.07.
06/12/17
BMOC
06/12/17
NO CHANGE
Target $43
BMOC
Outperform
Coherus Biosciences weakness a buying opportunity, says BMO Capital
BMO Capital analyst Ian Somaiya said CHS-1701 CRL is disappointing but the issues raised are addressable, and expects a timely resolution and re-submission. The analyst lowered Coherus Biosciences' price target to $43 from $54, assuming a one-year delay in the US and reduced probability of an on-time European approval, but said to use weakness as a buying opportunity and maintains an Outperform rating.
06/12/17
COWN
06/12/17
NO CHANGE
Target $45
COWN
Outperform
Coherus Biosciences CHS-1701 CRL 'appears resolvable', says Cowen
Cowen analyst Ken Cacciatore said Coherus Biosciences' CHS-1701 CRL "appears resolvable," with a delay most likely being a year. There does not seem to be any specific issue with 1701, but the FDA would like further analysis with a more refined assay to ensure the highest quality possible, the analyst wrote. Cacciatore rates Coherus a Buy with a $45 price target.
06/12/17
JPMS
06/12/17
NO CHANGE
JPMS
Overweight
Coherus shares can hit $30-plus on 2018 approval, says JPMorgan
JPMorgan analyst Chris Schott said that while today's news from Coherus Biosciences of a complete response letter on CHS-1701 is "clearly disappointing," the letter appears "very much addressable." The FDA is requesting reanalysis of a subset of samples using a more sensitive immunogenicity assay, which likely will result in a one year delay in approval, Schott told investors earlier in a research note. He notes the FDA did not request additional clinical studies. Schott continues to believe CHRS-1701 will be one of the first approved biosimilar versions of Neulasta. He views today's selloff in Coherus shares as an overreaction and keeps an Overweight rating on the name. The analyst sees upside to $30 per share assuming CHS-1701 gets approved in 2018. Coherus in afternoon trading is down 27% to $14.98.

TODAY'S FREE FLY STORIES

CO

China Cord Blood

$12.49

0.18 (1.46%)

06:45
08/24/17
08/24
06:45
08/24/17
06:45
Technical Analysis
Technical View: China Cord Blood hits new highs in pre-market »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

TIF

Tiffany

$88.72

0.22 (0.25%)

06:44
08/24/17
08/24
06:44
08/24/17
06:44
Hot Stocks
Tiffany provides FY17 outlook »

Management's outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:43
08/24/17
08/24
06:43
08/24/17
06:43
Hot Stocks
Tiffany sees FY17 CapEx $250M »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:42
08/24/17
08/24
06:42
08/24/17
06:42
Earnings
Tiffany sees FY17 EPS growth of high single digits, consensus $3.95 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:40
08/24/17
08/24
06:40
08/24/17
06:40
Earnings
Tiffany reports Q2 adjusted EPS 92c, consensus 86c »

Reports Q2 revenue $960M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

HMLP

Hoegh LNG

$18.60

0.25 (1.36%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Earnings
Hoegh LNG reports Q2 EPS 28c, consensus 40c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 12

    Sep

WDC

Western Digital

$88.31

1.66 (1.92%)

, TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Periodicals
Western Digital consortium to offer $17.4B for Toshiba chip unit, Reuters says »

A consortium that…

WDC

Western Digital

$88.31

1.66 (1.92%)

TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

TOSBF

Toshiba, also use TOSYY

$2.88

0.064 (2.27%)

KKR

KKR

$18.57

-0.07 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$38.32

0.09 (0.24%)

06:36
08/24/17
08/24
06:36
08/24/17
06:36
Conference/Events
Exelon management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:35
08/24/17
08/24
06:35
08/24/17
06:35
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

DXLG

Destination XL

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Destination XL management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 31

    Aug

  • 28

    Sep

BDC

Belden

$73.25

0.08 (0.11%)

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Belden management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 06

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Hot Stocks
Hormel Foods acquires Ceratti brand for approximately $104M »

Hormel Foods announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Earnings
Hormel cuts FY EPS view to $1.54-$1.58 from low end of $1.65-$1.71 »

Consensus is $1.65.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Hot Stocks
Hormel Foods says faced 'record-high' input costs for two primary raw materials »

"We generated record…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

AVD

American Vanguard

$20.00

0.15 (0.76%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Conference/Events
American Vanguard management to meet with Oppenheimer »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Earnings
Hormel Foods reports Q3 EPS 34c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

WBC

Wabco

$138.46

0.22 (0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Hot Stocks
Wabco to acquire Sheppard for $145M »

WABCO announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

AIN

Albany International

$51.10

-0.2 (-0.39%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Conference/Events
Albany International management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 01

    Sep

  • 28

    Sep

EADSY

Airbus

$20.89

-0.015 (-0.07%)

, DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Periodicals
European regulator, Airbus issue software fix for A350, Reuters reports »

The European Aviation…

EADSY

Airbus

$20.89

-0.015 (-0.07%)

DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

SINGY

Singapore Airlines

CPCAY

Cathay Pacific

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTD

L Brands

06:30
08/24/17
08/24
06:30
08/24/17
06:30
Conference/Events
L Brands to host sales conference call »

Pre-Recorded August sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:30
08/24/17
08/24
06:30
08/24/17
06:30
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

BRCD

Brocade

$12.25

0.06 (0.49%)

, AVGO

Broadcom

$256.92

1.73 (0.68%)

06:22
08/24/17
08/24
06:22
08/24/17
06:22
Hot Stocks
China conditionally approves Broadcom's proposed acquisition of Brocade »

In a regulatory filing,…

BRCD

Brocade

$12.25

0.06 (0.49%)

AVGO

Broadcom

$256.92

1.73 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

FB

Facebook

$168.71

-0.93 (-0.55%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Facebook taps exec Andrew Bosworth to lead hardware efforts, BI reports »

Facebook has selected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 13

    Sep

GOOG

Alphabet

$927.00

2.31 (0.25%)

, GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Google could unveil new Pixel phones on October 5, Engadget reports »

Google (GOOG) could…

GOOG

Alphabet

$927.00

2.31 (0.25%)

GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

QCOM

Qualcomm

$52.23

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

NADL

North Atlantic Drilling

$1.19

0.02 (1.71%)

06:17
08/24/17
08/24
06:17
08/24/17
06:17
Earnings
North Atlantic Drilling reports Q2 EPS ($2.59), consensus ($2.97) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.